The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function

Biomaterials

Volumn 35, Issue 1, 2014, Pages 133-142

  Mayfield, Audrey E ^a   Tilokee, Everad L ^a   Latham, Nicholas ^a   McNeill, Brian ^a   Lam, Bu Khanh ^a   Ruel, Marc ^a   Suuronen, Erik J ^a   Courtman, David W ^b   Stewart, Duncan J ^b   Davis, Darryl R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Cell therapy; Encapsulation; Heart failure; Myocardial infarction

Indexed keywords

CARDIAC FUNCTIONS; CARDIAC STEM CELLS; CELL THERAPY; EFFECT OF ENCAPSULATION; HEART FAILURE; LONG-TERM RETENTION; MECHANICAL RETENTION; MYOCARDIAL INFARCTION;

BIOELECTRIC POTENTIALS; CELL DEATH; HEART; REPAIR; STEM CELLS;

ENCAPSULATION;

FIBRINOGEN; FIBRONECTIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC STEM CELL; CELL ADHESION; CELL ENCAPSULATION; CELL HYPOXIA; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART ATRIUM APPENDAGE; HEART FUNCTION; HEART INFARCTION; HUMAN; HUMAN CELL; HYDROGEL; MICROCAPSULE; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

CELL THERAPY; ENCAPSULATION; HEART FAILURE; MYOCARDIAL INFARCTION;

AGED; CELL ADHESION MOLECULES; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; FEMALE; HEART; HUMANS; HYDROGELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; STEM CELLS;

EID: 84887025229     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.085     Document Type: Article

References (29)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
2. Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E., Berman D., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379(9819):895-904.
3. Bolli R., Chugh A.R., D'Amario D., Loughran J.H., Stoddard M.F., Ikram S., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378(9806):1847-1857.
4. Bonios M., Terrovitis J., Chang C.Y., Engles J.M., Higuchi T., Lautamaki R., et al. Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. JNucl Cardiol 2011, 18(3):443-450.
5. Terrovitis J., Lautamaki R., Bonios M., Fox J., Engles J.M., Yu J., et al. Noninvasive quantification and optimization of acute cell retention by invivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. JAm Coll Cardiol 2009, 54(17):1619-1626.
6. Liu J., Narsinh K.H., Lan F., Wang L., Nguyen P.K., Hu S., et al. Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging. Circ Cardiovasc Imaging 2012, 5:481-490.
7. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106(10):1570-1581.
8. Cheng K., Blusztajn A., Shen D., Li T.S., Sun B., Galang G., et al. Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials 2012, 33(21):5317-5324.
9. Cheng K., Malliaras K., Shen D., Tseliou E., Ionta V., Smith J., et al. Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. JAm Coll Cardiol 2012, 59(3):256-264.
10. Cheng K., Shen D., Xie Y., Cingolani E., Malliaras K., Marban E. Brief report: mechanism of extravasation of infused stem cells. Stem Cells 2012, 30(12):2835-2842.
11. Terrovitis J.V., Smith R.R., Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106(3):479-494.
12. Reinecke H., Murry C.E. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. JMol Cell Cardiol 2002, 34(3):251-253.
13. Karoubi G., Ormiston M.L., Stewart D.J., Courtman D.W. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials 2009, 30(29):5445-5455.
14. Grossmann J. Molecular mechanisms of "detachment-induced apoptosis-anoikis". Apoptosis 2002, 7(3):247-260.
15. Davis D.R., Kizana E., Terrovitis J., Barth A.S., Zhang Y., Smith R.R., et al. Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. JMol Cell Cardiol 2010, 49(2):312-321.
16. Ruel M., Suuronen E.J., Song J., Kapila V., Gunning D., Waghray G., et al. Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. JThorac Cardiovasc Surg 2005, 130(3):633-639.
17. Pfaffl M.W. Anew mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.
18. Pankov R., Yamada K.M. Fibronectin at a glance. JCell Sci 2002, 115(Pt 20):3861-3863.
19. Knowlton A.A., Connelly C.M., Romo G.M., Mamuya W., Apstein C.S., Brecher P. Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. JClin Invest 1992, 89(4):1060-1068.
20. Takagi J., Strokovich K., Springer T.A., Walz T. Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J 2003, 22(18):4607-4615.
21. Konstandin M.H., Toko H., Gastelum G.M., Quijada P., De La Torre A., Quintana M., et al. Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction. Circ Res 2013, 113(2):115-125.
22. Davis D.R., Ruckdeschel S.R., Marban E. Human cardiospheres are a source of stem cells with cardiomyogenic potential. Stem Cells 2010, 28(5):903-904.
23. Chimenti I., Smith R.R., Li T.S., Gerstenblith G., Messina E., Giacomello A., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010, 106(5):971-980.
24. Cheng K., Shen D., Smith J., Galang G., Sun B., Zhang J., et al. Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction. Biomaterials 2012, 33(10):2872-2879.
25. Jeevanantham V., Butler M., Saad A., Abdel-Latif A., Zuba-Surma E.K., Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012, 126(5):551-568.
26. Delewi R., Andriessen A., Tijssen J.G., Zijlstra F., Piek J.J., Hirsch A. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 2013, 99(4):225-232.
27. Yu J., Du K.T., Fang Q., Gu Y., Mihardja S.S., Sievers R.E., et al. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 2010, 31(27):7012-7020.
28. Cheng K., Malliaras K., Li T.S., Sun B., Houde C., Galang G., et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant 2012, 21(6):1121-1135.
29. Klomp M., Beijk M.A., de Winter R.J. Genous endothelial progenitor cell-capturing stent system: a novel stent technology. Expert Rev Med Devices 2009, 6(4):365-375.